Adipobiology of stem cell-based therapy: Secretome insight

Biomedical Reviews

Volumn 21, Issue , 2010, Pages 57-63

  Tonchev, Anton B ^a   Bełtowski, Jerzy ^b   Fiore, Marco ^c   Rančić, Gorana ^d   Chechi, Kanta ^a   Bojanić, Vladmila ^d   Kostov, Dimitar D ^e   Chaldakov, George N ^a  

^a MEDICAL UNIVERSITY OF VARNA   (Bulgaria)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c CNR   (Italy)

^d UNIVERSITY OF NI   (Serbia)

^e UNIVERSITY HOSPITAL ST MARINA   (Bulgaria)

Author keywords

Adipokines; Adipose tissue; Diseases; Growth factors; Secretion

Indexed keywords

SECRETORY PROTEIN;

ADIPOCYTE; ADIPOSE DERIVED STEM CELL; BROWN ADIPOSE TISSUE; CELL ACTIVITY; CELL DIFFERENTIATION; CELL ENGINEERING; CELL POPULATION; CELL PROLIFERATION; CELLULAR SECRETION; CEREBROVASCULAR ACCIDENT; ENTEROPATHY; HEART INFARCTION; HUMAN; LIVER DISEASE; MEDICAL ETHICS; REGENERATIVE MEDICINE; REVIEW; RISK ASSESSMENT; STEM CELL TRANSPLANTATION; TISSUE STRUCTURE; WHITE ADIPOSE TISSUE;

EID: 84859249773     PISSN: 1310392X     EISSN: None     Source Type: Journal    
DOI: 10.14748/bmr.v21.47     Document Type: Review

References (70)

1. Scanu AM, Bull TJ, Cannas S, et al. Mycobacterium avium subspecies paratuberculosis infection in cases of irritable bowel syndrome and comparison with Crohn's disease and Johne's disease: common neural and immune pathogenicities. J Clin Microbiol 2007;45:3883-3890.
2. Nagajyothi F, Desruisseaux MS, Jelicks LA, et al. Perspectives on adipose tissue, Chagas disease and implications for the metabolic syndrome. Interdiscip Perspect Infect Dis 2009; July 26: in print.
3. Erol A. Visceral adipose tissue specific persistence of Mycobacterium tuberculosis may be reason for the metabolic syndrome. Med Hypotheses 2008;71:222-228.
4. Frühback G, Becerril S, Sáinz N, et al. BAT: a new target for human obesity? Trends Pharmacol Sci 2009; 30:387-396.
5. van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, et al. Cold-activated brown adipose tissue in healthy men. N Engl J Med 2009;360:1500-1508.
6. Chaldakov GN, Fiore M, Tonchev AB, Hristova MG, Rancic G, Aloe L. The adipose tissue as a third brain. Obesity Metab 2009; 5: 94-96.
7. Chaldakov GN, Fiore M, Tonchev AB, Aloe L. Neuroadipology: a novel component of neuroendocrinology. Cell Biol Int 2010; 34:1051-1053
8. Friedman JM. Leptin at 14 yr of age: an ongoing story. Am J Clin Nutr 2009; 89: 973S-979S.
9. Chaldakov GN, Stankulov IS, Hristova M, Ghenev PI. Adipobiology of disease: adipokines and adipokine-targeted pharmacology. Curr Pharm Des 2003; 9:1023-1031.
10. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92:347-355.
11. Adachi J, Kumar C, Zhang Y, Mann M. In-depth analysis of the adipocyte proteome by mass spectrometry and bioinformatics. Mol Cell Proteomics 2007; 6:1257-1273.
12. Bełtowski J. Apelin and visfatin: unique "beneficial" adipokines upregulated in obesity? Med Sci Monit 2006; 12: RA112-119.
13. Töre F, Tonchev AB, Fiore M, Tunçel N, Atanassova P, Aloe L, et al. From adipose tissue protein secretion to adipopharmacology of disease. Immunol Endocr Metab Agents Med Chem 2007; 7: 149-155.
14. Alvarez-Llamas G, Szalowska E, de Vries MP, et al. Characterization of the human visceral adipose tissue secretome. Mol Cell Proteomics 2007;6:589-600.
15. Renes J, Rosenow A, Mariman E. Novel adipocyte features discovered by adipoproteomics. Adipobiology 2009;1:5-14.
16. Deng ZB, Poliakov A, Hardy RW, et al. Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance. Diabetes 2009; August 12: in print.
17. Chaldakov GN, Vankov VN. Morphological aspects of secretion in the arterial smooth muscle cell, with special reference to the Golgi complex and microtubular cytoskeleton. Atherosclerosis 1986; 61:175-192.
18. Aoki N, Jin-no S, Nakagawa Y et al. Identification and characterization of microvesicles secreted by 3T3-L1 adipocytes: redox-and hormone-dependent induction of milk fat globule-epidermal growth factor 8-associated microvesicles. Endocrinology 2007;148:3850-3862.
19. Blouin K, Veilleux A, Luu-The V, Tchernof A. Androgen metabolism in adipose tissue: recent advances. Mol Cell Endocrinol 2009; 301:97-103.
20. Matias I. The EC system in the adipose tissue and endocrine pancreas. In: J-P Després, V Di Marzo, editors. Abdominal Obesity and the Endocannabinoid System. From Basic Aspects to Clinical Management of Related Cardiometabolic Risk. Informa Healthcare USA, Inc. 2009. pp 153-162.
21. Canová NK, Lincová D, Kmonícková E, et al. Nitric oxide production from rat adipocytes is modulated by beta3-adrenergic receptor agonists and is involved in a cyclic AMP-dependent lipolysis in adipocytes. Nitric Oxide 2006; 14: 200-211.
22. Beltowski J. Leptin and atherosclerosis. Atherosclerosis 2006; 189: 47-60.
23. Chaldakov GN, Tonchev AB, Fiore M, Hristova MG, Pancheva R, Rancic G, et al. Implications for the future of obesity management. In: G Frühbeck, editor. Peptides in Energy Balance and Obesity. CAB International. 2009, pp 369-389.
24. Westcott ED, Mattacks CA, Windsor AC, et al. Perinodal adipose tissue and fatty acid composition of lymphoid tissues in patients with and without Crohn's disease and their implications for the etiology and treatment of CD. Ann NY Acad Sci 2006; 1072:395-400.
25. Paul G, Schäffler A, Neumeier M, Fürst A, et al. Profiling adipocytokine secretion from creeping fat in Crohn's disease. Inflamm Bowel Dis 2006;12:471-477.
26. Ikejima K, Okumura K, Kon K, et al. Role of adipocytokines in hepatic fibrogenesis. J Gastroenterol Hepatol 2007;22 (Suppl 1):S87-92.
27. Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, et al. Non-alcoholic fatty liver disease-new view. Pol Merkur Lekarski 2008;24:568-571.
28. Giordano V, Peluso G, Iannuccelli M, et al. Systemic and brain metabolic dysfunction as a new paradigm for approaching Alzheimer's dementia. Neurochem Res 2007; 32: 555-567.
29. Tezapsidis N, Johnston JM, Smith MA, et al. Leptin: a novel therapeutic strategy for Alzheimer's disease. J Alzheimers Dis 2009; 16: 731-740.
30. Luchsinger JA, Gustafson DR. Adiposity and Alzheimer's disease. Curr Opin Clin Nutr Metab Care 2009; 12:15-21.
31. Phan J, Hickey MA, Zhang P, et al. Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models. Hum Mol Genet 2009; 18: 1006-1016.
32. Hecther O, Halkerston IDK. On the action of mammalian hormones. In: The Hormones. Volume 5, Academic Press Inc., New York, 1964. pp 697-816.
33. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2008; 2:313-319.
34. Peroni D, Scambi I, Pasini A, et al. Stem molecular signature of adipose-derived stromal cells. Exp Cell Res 2008;314:603-615.
35. Fraser JK, Wulur I, Alfonso Z, et al. Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol 2006; 24: 150-154.
36. Bunnell BA, Flaat M, Gagliardi C, et al. Adipose-derived stem cells: isolation, expansion and differentiation. Methods 2008; 45:115-120.
37. Cherubino M, Marra KG. Adipose-derived stem cells for soft tissue reconstruction. Regen Med 2009;4:109-117.
38. Ohta Y, Takenaga M, Tokura Y et al. Mature adipocyte-derived cells, dedifferentiated fat cells (DFAT) promote functional recovery from spinal cord injury-induced motor dysfunction in rats. Cell Transplant 2008;17:877-886.
39. Dhar S, Yoon ES, Kachgal S, et al. Long-term maintenance of neuronally differentiated human adipose tissue-derived stem cells. Tissue Eng 2007; 13: 2625-2632.
40. Zvonic S, Lefevre M, Kilroy G, et al. Secretome of primary cultures of human adipose-derived stem cells: modulation of serpins by adipogenesis. Mol Cell Proteomics 2007;6:18-28.
41. Aluigi MG, Coradeghini R, Guida C, et al. Pre-adipocytes commitment to neurogenesis 1: preliminary localisation of cholinergic molecules. Cell Biol Int 2009; 33: 594-601.
42. Riordan NH, Ichim TE, Min WP, et al. Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. J Transl Med 2009; 7: 29.
43. Meliga E, Strem BM, Duckers HJ, Serruys PW. Adipose-derived cells. Cell Transplant 2007; 16: 963-970.
44. Cai L, Johnstone BH, Cook TG, et al. IFATS collection: Human adipose tissue-derived stem cells induce angiogenesis and nerve sprouting following myocardial infarction, in conjunction with potent preservation of cardiac function. Stem Cells 2009; 27: 230-237.
45. Lee EY, Xia Y, Kim WS, et al. Hypoxia-enhanced wound-healing function of adipose-derived stem cells: increase in stem cell proliferation and up-regulation of VEGF and bFGF. Wound Repair Regen 2009;17:540-547.
46. Billon N, Iannarelli P, Monteiro MC, et al. The generation of adipocytes by the neural crest. Development 2007;134:2283-2292.
47. Billon N, Monteiro MC, Dani C. Developmental origin of adipocytes: new insights into a pending question. Biol Cell 2008; 100:563-575.
48. Gonzalez-Rey E, Anderson P, González MA et al. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 2009;58:929-939.
49. Garcia-Olmo D, Herreros D, Pascual I, et al. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum 2009;52:79-86.
50. González MA, Gonzalez-Rey E, Rico L, et al. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum 2009;60:1006-1019.
51. Roccio M, Goumans MJ, Sluijter JP, Doevendans PA. Stem cell sources for cardiac regeneration. Panminerva Med 2008; 50:19-30.
52. Sanz-Ruiz R, Fernández-Santos E, Domínguez-Muñoa M, Parma R, Villa A, Fernández L, et al. Early translation of adipose-derived cell therapy for cardiovascular disease. Cell Transplant 2009; 18: 245-254.
53. Safford KM, Rice HE. Stem cell therapy for neurologic disorders: therapeutic potential of adipose-derived stem cells. Curr Drug Targets 2005; 6:57-62.
54. Reina MA, Franco CD, López A, Dé Andrés JA, van Zundert A. Clinical implications of epidural fat in the spinal canal. A scanning electron microscopic study. Acta Anaesthesiol Belg 2009; 60:7-17.
55. Zhao L, Wei X, Ma Z, Feng D, Tu P, Johnstone BH, et al. Adipose stromal cells-conditional medium protected glutamate-induced CGNs neuronal death by BDNF. Neurosci Lett 2009; 452:238-240.
56. Cobacho N, Serrano AB, Casarejos MJ, Mena MA, Paíno CL. Use of transduced adipose tissue stromal cells as biologic minipumps to deliver levodopa for the treatment of neuropathic pain: possibilities and limitations. Cell Transplant 2009; 18:1341-1358.
57. Xu R, Chen J, Cong X, Hu S, Chen X. Lovastatin protects mesenchymal stem cells against hypoxia-and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2. J Cell Biochem 2008; 103:256-269.
58. Zhang W, Su X, Gao Y, et al. Berberine protects mesenchymal stem cells against hypoxia-induced apoptosis in vitro. Biol Pharm Bull 2009; 32:1335-1342.
59. Nan GX, Li M, Liao WH, et al. Effect of valproic acid on endogenous neural stem cells proliferation in rat model of spinal cord injury. Neural Regen Res 2009; 4:513-517.
60. Chaldakov GN, Fiore F, Tonchev AB, Dimitrov D, Pancheva R, Rancic G, et al. Homo obesus: A metabotrophin-deficient species. Pharmacology and nutrition insight. Curr Pharm Des 2007; 13: 2176-2179.
61. Sadan O, Shemesh N, Cohen Y, Melamed E, Offen D. Adult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseases. Isr Med Assoc J 2009; 11:201-204.
62. Wei X, Zhao L, Zhong J, et al. Adipose stromal cells-secreted neuroprotective media against neuronal apoptosis. Neurosci Lett 2009;462:76-79.
63. McCoy MK, Martinez TN, Ruhn KA, et al. Autologous transplants of adipose-derived adult stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson's disease. Exp Neurol 2008;210:14-29.
64. Sanz-Ruiz R, Fernández-Santos E, Domínguez-Muñoa M, et al. Early translation of adipose-derived cell therapy for cardiovascular disease. Cell Transplant 2009;18:245-254.
65. Lin G, Banie L, Ning H, et al. Potential of adipose-derived stem cells for treatment of erectile dysfunction. J Sex Med 2009; 6 (Suppl 3):320-327.
66. Chaldakov GN, Fiore M, Tonchev AB, Hristova MG, Nikolova V, Aloe L. Tissue with high intelligence quotient. Adipose-derived stem cells in neural regeneration. Neural Regen Res 2009; 4: 1116-1120.
67. Zhu Y, Liu T, Song K, et al. Adipose-derived stem cell: a better stem cell than BMSC. Cell Biochem Funct 2008;26:664-675.
68. Hidalgo J, Penkowa M, Espejo C, Martinez-Cáceres EM, et al. Expression of metallothionein-I,-II,-III in Alzheimer's disease and animal models of neuroinflammation. Exp Biol Med 2006; 254: 327-332.
69. Skalnikova H, Motlik J, Gadher SJ, Kovarova H. Mapping of the secretome of primary isolates of mammalian cells, stem cells and derived cell lines. Proteomics 2010 Dec 15; in press.
70. Salgado AJ, Reis RL, Sousa NJ, Gimble JM. Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Curr Stem Cell Res Ther 2010;5:103-110.